Core Viewpoint - The company, Xianruida Medical-B (06669.HK), has received registration approval from the National Medical Products Administration of China for its controllable mechanical embolization spring coil, which is designed for peripheral vascular applications [1] Group 1: Product Details - The product is intended for the embolization of peripheral vascular aneurysms, arteriovenous malformations, and arteriovenous fistulas [1] - It features a controllable release mechanism that ensures a stable and precise deployment of the spring coil, enhancing operational control and safety [1] - The product is available in both 2D and 3D structures, allowing for broad adaptability to clinical needs [1] Group 2: Market Strategy - The company plans to initiate marketing activities in China at an appropriate time following the approval [1]
先瑞达医疗-B(06669.HK)：外周可控机械解脱带纤维毛弹簧圈的注册申请获中国国家药品监督管理局批准